Literature DB >> 24005823

L-carnitine exposure and mitochondrial function in human neuronal cells.

David A Geier1, Mark R Geier.   

Abstract

L-Carnitine is a naturally occurring substance required in mammalian energy metabolism that functions by facilitating long-chain fatty acid entry into cellular mitochondria, thereby delivering substrate for oxidation and subsequent energy production. It has been purposed that L-carnitine may improve and preserve cognitive performance, and may lead to better cognitive aging through the life span, and several controlled human clinical trials with L-carnitine support the hypothesis that this substance has the ability to improve cognitive function. We further hypothesized that, since L-carnitine is an important co-factor of mammalian mitochondrial energy metabolism, acute administration of L-carnitine to human tissue culture cells should result in detectable increases in mitochondrial function. Cultures of SH-SY-5Y human neuroblastoma and 1321N1 human astrocytoma cells grown in 96-well cell culture plates were acutely administered L-carnitine hydrochloride, and then, mitochondrial function was assayed using the colorimetric 2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt cell assay kit in a VERSAmax tunable microplate reader. Significant increases in mitochondrial function were observed when human neuroblastoma or human astrocytoma cells were exposed to 100 nM (20 μg L-carnitine hydrochloride/L) to 100 μM (20 mg L-carnitine hydrochloride/L) concentrations of L-carnitine hydrochloride in comparison to unexposed cells, whereas no significant positive effects were observed at lower or higher concentrations of L-carnitine hydrochloride. The results of the present study provide insights for how L-carnitine therapy may significantly improve human neuronal function, but we recommend that future studies further explore different derivatives of L-carnitine compounds in different in vitro cell-based systems using different markers of mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005823     DOI: 10.1007/s11064-013-1144-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

1.  Protective effect of L-carnitine against H(2)O(2)-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells.

Authors:  Jing Yu; Junli Ye; Xiaojin Liu; Yantao Han; Chunbo Wang
Journal:  Neurol Res       Date:  2011-09       Impact factor: 2.448

Review 2.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

Authors:  Michael V Berridge; Patries M Herst; An S Tan
Journal:  Biotechnol Annu Rev       Date:  2005

Review 3.  Carnitine--a known compound, a novel function in neural cells.

Authors:  K A Nałecz; M J Nałecz
Journal:  Acta Neurobiol Exp (Wars)       Date:  1996       Impact factor: 1.579

4.  L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.

Authors:  Mariano Malaguarnera; Lisa Cammalleri; Maria Pia Gargante; Marco Vacante; Valentina Colonna; Massimo Motta
Journal:  Am J Clin Nutr       Date:  2007-12       Impact factor: 7.045

Review 5.  Carnitine metabolism and deficit--when supplementation is necessary?

Authors:  A Evangeliou; D Vlassopoulos
Journal:  Curr Pharm Biotechnol       Date:  2003-06       Impact factor: 2.837

6.  An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

Authors:  N W Roehm; G H Rodgers; S M Hatfield; A L Glasebrook
Journal:  J Immunol Methods       Date:  1991-09-13       Impact factor: 2.303

7.  Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine.

Authors:  L Battistin; G Pizzolato; M Dam; C Da Col; N Perlotto; B Saitta; N Borsato; M Calvani; G Ferlin
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

8.  A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

Authors:  David A Geier; Janet K Kern; Georgia Davis; Paul G King; James B Adams; John L Young; Mark R Geier
Journal:  Med Sci Monit       Date:  2011-06

Review 9.  Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and L-carnitine.

Authors:  Lauren Owen; Sandra I Sunram-Lea
Journal:  Nutrients       Date:  2011-08-10       Impact factor: 5.717

10.  Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds.

Authors:  D A Geier; P G King; M R Geier
Journal:  Toxicol Environ Chem       Date:  2009-06-11       Impact factor: 1.437

View more
  2 in total

1.  The Alteration of L-Carnitine Transport and Pretreatment Effect under Glutamate Cytotoxicity on Motor Neuron-Like NSC-34 Lines.

Authors:  Asmita Gyawali; Seung Jae Hyeon; Hoon Ryu; Young-Sook Kang
Journal:  Pharmaceutics       Date:  2021-04-14       Impact factor: 6.321

2.  Serum Metabolomics of Early Postoperative Cognitive Dysfunction in Elderly Patients Using Liquid Chromatography and Q-TOF Mass Spectrometry.

Authors:  Gang Qian; YueLan Wang
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.